BeiBangAnBPC-157
Ordered BPC-157 from BeiBangAn? Mail in a sample (US only) and let us test it for free.
Test my supplyBeiBangAn's BPC-157 profile is held back by a 98.5% purity miss amid otherwise passing identity, quantity, and later purity results. Sparse batch identifiers and thin price/review corroboration keep the evidence less settled.
Corporate records, forum archives, and web assets point to a short-lived Telegram storefront with SigmaAudley/AkumaRift continuity, not a mature manufacturer. The full dossier maps the LNPeptide overlap, domain trail, payment/contact rails, and unresolved Hong Kong company lead.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including BeiBangAn rows.
Cancel anytime
About BeiBangAn test results from Finnrick
BeiBangAn is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 7 peptides and 71 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible BeiBangAn peptides in this dataset are BPC-157 (4 tests), GHK-Cu (5 tests) and PT-141 (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 71 recent tests. It also includes 1 correction related to this vendor.
Ordered BPC-157 from BeiBangAn? Mail in a sample (US only) and let us test it for free.
Test my supply